The poultry vaccines industry in the Nordics focuses on protecting birds from diseases that can impact health and production. Occasional outbreaks can lead to economic losses, compelling innovative solutions from biotech companies and pharmaceutical firms dedicated to vaccine development. These companies craft doses aimed at preventing avian flu, Newcastle disease, and other critical illnesses affecting poultry. As sustainable practices gain importance, the industry is moving towards developing more effective, temperature-stable vaccines that minimize environmental footprints while enhancing health outcomes. Moreover, collaborations between research institutions and private enterprises are accelerating advancements in this essential agricultural sector.


The roster of investors in the poultry vaccines sector includes private equity and venture capital firms with roots in key Nordic cities such as Stockholm and Copenhagen. Established between 1963 and 2018, these entities vary in size, with some employing fewer than ten people while others boast thousands. In 2024, total investments ranged from singular transactions to several dozen, showcasing active engagement in biotech and agricultural health. This collective illustrates a strong commitment to enhancing poultry health through innovative vaccine solutions while fostering growth within a critical industry.


Top 9 Poultry Vaccines Investors in the Nordics


1. EQT Group

  • Website: eqtgroup.com
  • Type: Private Equity
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 1994
  • Headcount: 1001-5000
  • Number of deals in 2024: 30
  • LinkedIn: eqt-partners

EQT Group is a prominent private equity firm based in Stockholm, Sweden, founded in 1994. The firm specializes in a diverse range of investment strategies, including private equity, infrastructure, real estate, growth equity, and venture capital. EQT serves institutional investors by providing expertise in managing varied investment portfolios across multiple sectors and geographies. Notably, EQT has made significant investments in the veterinary services sector, acquiring companies like Evidensia Djursjukvård, the Nordic market leader in veterinary services, and IVC Evidensia, Europe's largest veterinary care provider. These transactions highlight EQT's commitment to the animal health industry, which is closely related to poultry health and vaccines, suggesting a strategic interest that could extend to poultry vaccines in the future.


2. Industrifonden

  • Website: industrifonden.com
  • Type: Venture Capital
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 1979
  • Headcount: 11-50
  • Number of deals in 2024: 9
  • LinkedIn: industrifonden

Industrifonden is a venture capital fund based in Stockholm, Sweden, founded in 1979. The fund specializes in investing in early-stage companies, particularly in the fields of Deep Tech, Life Science, and Transformative Tech. Industrifonden provides financial support and strategic guidance to startups, helping them scale their innovative solutions. In recent years, Industrifonden has been involved in several significant transactions in the life sciences sector, including investments in Minervax, a biotech company focused on developing vaccines. Notably, Industrifonden participated in Minervax's Series B and Series C funding rounds, which raised substantial amounts to advance the development of a vaccine candidate. This involvement in vaccine development highlights Industrifonden's commitment to supporting innovative health solutions, which could extend to the poultry vaccines industry as well.


3. Sunstone Life Science Ventures


Sunstone Life Science Ventures is a venture capital firm based in Copenhagen, Denmark, founded in 2007. The firm specializes in early-stage investments in life science companies, focusing on innovations in therapeutics, medical technology, and diagnostics. Sunstone provides not only funding but also business development support to help portfolio companies navigate the path from research to market. Notably, Sunstone has been involved in several funding rounds for MinervaX, a Danish biotech company developing a vaccine candidate for Group B Streptococcus (GBS), which has received significant funding including a €72M financing round in December 2022. This funding is aimed at advancing the late-stage development of the GBS vaccine candidate, which highlights Sunstone's active role in the vaccine development space, potentially extending to other vaccine sectors, including poultry vaccines.


4. Flerie

  • Website: flerie.com
  • Type: Venture Capital
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 2011
  • Headcount: 1-10
  • Number of deals in 2024: 2
  • LinkedIn: flerie

Flerie is a venture capital firm based in Stockholm, Sweden, founded in 2011. The firm specializes in life sciences, with a strong focus on biotech and pharmaceutical investments. Flerie supports its portfolio of over 30 companies by providing resources and expertise to navigate drug development challenges. The firm operates primarily in Europe, Israel, and the US, aiming to create long-term value through strategic investments. Notably, Flerie has participated in funding rounds for companies like Prokarium, which is developing innovative synthetic biology techniques for vaccines. In 2018, Flerie invested in Prokarium's funding round aimed at creating new vaccines against various diseases, showcasing their involvement in vaccine development. This aligns with their broader focus on life sciences and indicates their potential interest in vaccine technologies, including those applicable to poultry.


5. Polaris Private Equity


Polaris Private Equity is a private equity firm based in Copenhagen, Denmark, founded in 1998. The firm specializes in investment management, focusing on supporting mid-sized companies in the Nordic region through tailored investment strategies, including private equity, flexible capital, and public equity. Polaris partners with management teams to drive growth and operational improvements, helping these companies realize their full potential. Notably, Polaris has been involved in significant transactions within the poultry sector, such as the acquisition of HAMLET PROTEIN in 2007, which provides protein products for animal nutrition, including poultry. More recently, in 2024, Polaris acquired FaunaPharma and Salfarm, both of which are involved in animal health, further indicating their engagement in sectors that may include poultry vaccines.


6. Maki.vc

  • Website: maki.vc
  • Type: Venture Capital
  • Headquarters: Helsinki, Uusimaa, Finland
  • Founded year: 2018
  • Headcount: 1-10
  • Number of deals in 2024: 11
  • LinkedIn: maki-vc

Maki.vc is a venture capital firm based in Helsinki, Finland, founded in 2018. The firm specializes in seed-stage investments in deep tech and brand-driven companies, providing funding and support to early-stage startups to help them navigate growth and innovation challenges. Maki.vc operates primarily in the Nordic region but maintains a global investment mandate. Notably, Maki.vc has participated in several relevant transactions, including a seed funding round for Onego Bio, which raised EUR 10 million to commercialize technology for producing egg white without chickens, directly impacting the poultry industry. Additionally, they were involved in funding Baseimmune, a biotech company developing vaccines, which, while not specific to poultry, indicates their engagement in the vaccine development space. These transactions highlight Maki.vc's potential relevance to the poultry vaccines sector.


7. Altor Equity Partners

  • Website: altor.com
  • Type: Private Equity
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 2003
  • Headcount: 51-200
  • Number of deals in 2024: 6
  • LinkedIn: altor

Altor Equity Partners is a private equity investment management firm based in Stockholm, Sweden, founded in 2003. The firm specializes in providing consulting services across various sectors, including technology and consumer products, with a strong emphasis on operational efficiency and sustainable growth. Altor has made significant investments in the animal and aquaculture feed industry, notably acquiring Hamlet Protein, a Danish producer focused on high value-add young animal feed, which is crucial for poultry health. Additionally, their acquisition of Meyn Food Processing Technology, a leader in poultry processing solutions, further highlights their engagement in the poultry sector. Altor's strategic investments in companies like Haarslev Industries and EWOS also reflect their commitment to enhancing the operational capabilities of businesses within the animal health and nutrition space.


8. Finnfund

  • Website: finnfund.fi
  • Type: Corporate
  • Headquarters: Helsinki, Uusimaa, Finland
  • Founded year: 1980
  • Headcount: 51-200
  • Number of deals in 2024: 7
  • LinkedIn: finnfund

Finnfund is a not-for-profit development financier and impact investor based in Helsinki, Finland, founded in 1980. The organization focuses on creating sustainable futures by investing in companies that address global development challenges, particularly in developing countries. Finnfund provides investment and advisory services to promote economic growth and sustainability across various sectors. Notably, Finnfund has invested in EthioChicken, an Ethiopian chicken company, with a US$5 million investment aimed at job creation, food security, and poverty elimination. This investment highlights Finnfund's commitment to the poultry industry and its potential relevance to poultry vaccines, as it supports the broader agricultural ecosystem. Additionally, Finnfund has been involved in other transactions, such as supporting farmers through Proximity Finance, which further emphasizes its focus on sustainable agricultural practices.


9. Knutsson Holdings AB

  • Website: knutsson.se
  • Type: Corporate
  • Headquarters: Gothenburg, Västra Götaland, Sweden
  • Founded year: 1963
  • Headcount: 1-10
  • Number of deals in 2024: 2
  • LinkedIn: knutsson-holdings

Knutsson Holdings AB is a family-owned investment holding company based in Gothenburg, Sweden, founded in 1963. The firm invests in a diverse range of industries, including eGaming, healthcare, and real estate, providing capital and strategic guidance to foster growth and innovation. Notably, they participated in a venture round for Intervacc, which raised approximately $4.4 million in December 2010. Intervacc is known for its work in developing vaccines for animals, including poultry, which aligns with the poultry vaccines sector. However, the company's broader investment strategy spans multiple industries, indicating a diversified approach rather than a focused commitment to poultry vaccines.



Poultry Vaccines Insights: Key Investors in the Nordics


InvestorHeadquarterSizeFoundedDeals 2024
EQT GroupStockholm, Stockholm, Sweden1001-5000199430
IndustrifondenStockholm, Stockholm, Sweden11-5019799
Sunstone Life Science VenturesCopenhagen, Denmark1-1020071
FlerieStockholm, Stockholm, Sweden1-1020112
Polaris Private EquityCopenhagen, Denmark51-20019984
Maki.vcHelsinki, Uusimaa, Finland1-10201811
Altor Equity PartnersStockholm, Stockholm, Sweden51-20020036
FinnfundHelsinki, Uusimaa, Finland51-20019807
Knutsson Holdings ABGothenburg, Västra Götaland, Sweden1-1019632


Want to find more investors focusing on the poultry vaccines industry?

If you want to find more investors that are active in the poultry vaccinesindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!